Literature DB >> 7144999

Comparison of two molecular species of ethanolamine plasmalogen in multiple sclerosis and normal myelin.

J M Boggs, D Stamp, M A Moscarello.   

Abstract

A TLC procedure which resolves two molecular species of ethanolamine plasmalogen, Pl-PE-1 and Pl-PE-2, was used to compare the ratio of these was species in myelin isolated from normal appearing white matter from brains of 17 multiple sclerosis (MS) patients, 17 normal (N) individuals, 1 patient with subacute sclerosing panencephalitis (SSPE) and 1 patient with a non-demyelinating neurological disease (OND). One of these species (Pl-PE-2) has been reported to be unique to myelin and has primarily 18:1 in both the 1 and 2 positions of glycerol. The other species (Pl-PE-1) is also present in other membranes and has primarily a saturated chain in the 1 position and a polyunsaturated chain in the 2 position. The Pl-PE-1 to Pl-PE-2 ratio was quantitated by scanning the plates with a densitometer. The ratio was similar to normal in most of the MS samples, 0.88 +/- 0.09, but was much less th an normal in 4 of the MS samples and the SSPE sample. This is attributed to increased decomposition or hydrolysis of Pl-PE-1 relative to Pl-PE-2 at some stage, either during the disease process or due to post-mortem decomposition. Although the reason for the enhanced decomposition of Pl-PE-1 is not known it suggests that Pl-PE-2 is more stable chemically. This may be related to the unique occurrence of Pl-PE-2 in myelin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7144999     DOI: 10.1007/bf00965135

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

1.  Metabolism of glycerophospholipids of myelin and microsomes in rat brain. Reutilization of precursors.

Authors:  S L Miller; J A Benjamins; P Morell
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

2.  Preparation and properties of phosphatidal ethanolamine from bovine white matter.

Authors:  M F Frosolono; M Marsh
Journal:  Chem Phys Lipids       Date:  1973-04       Impact factor: 3.329

3.  [On the activity of phospholipase A2 compared with 1-alk-1'-enyl-2-acyl- and 1-alkyl-2-acyl-glycerophosphatides in multiple sclerosis (author's transl)].

Authors:  H Woelk; K Peiler-Ichikawa
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

4.  Lipid and fatty acid composition of myelin purified from normal and MS brains.

Authors:  H Woelk; P Borri
Journal:  Eur Neurol       Date:  1973       Impact factor: 1.710

5.  Plasmalogenase activity in normal and demyelinating tissue of the central nervous system.

Authors:  G B Ansell; S Spanner
Journal:  Biochem J       Date:  1968-06       Impact factor: 3.857

6.  Changes in fatty acid composition of human brain myelin lipids during maturation.

Authors:  L Svennerholm; M T Vanier; B Jungbjer
Journal:  J Neurochem       Date:  1978-06       Impact factor: 5.372

7.  The diminution of the myelin ethanolamine plasmalogen in brain of the Jimpy mouse and brain and spinal cord of the Quaking mouse as visualized by thin-layer chromatography.

Authors:  M H Hack; F M Helmy
Journal:  J Chromatogr       Date:  1978-03-01

8.  Chromatographic analysis of the neutral and phosphatide glyceryl ethers from various biological sources.

Authors:  M H Hack; F M Helmy
Journal:  J Chromatogr       Date:  1975-04-09

9.  Lipid composition of the normal human brain: gray matter, white matter, and myelin.

Authors:  J S O'Brien; E L Sampson
Journal:  J Lipid Res       Date:  1965-10       Impact factor: 5.922

10.  Plasmalogenase is elevated in early demyelinating lesions.

Authors:  L A Horrocks; S Spanner; R Mozzi; S C Fu; R A D'Amato; S Krakowka
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

View more
  1 in total

1.  Lipid abnormalities in succinate semialdehyde dehydrogenase (Aldh5a1-/-) deficient mouse brain provide additional evidence for myelin alterations.

Authors:  G Barcelo-Coblijn; E J Murphy; K Mills; B Winchester; C Jakobs; O C Snead; K M Gibson
Journal:  Biochim Biophys Acta       Date:  2007-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.